Skip to main content Skip to section navigation Skip to footer
ProMIS Neurosciences, Inc.
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Business Advisory Board
  • Our Science
  • Product Pipeline
    • Overview
    • Alzheimer’s Disease
    • ALS
    • MSA
    • Parkinson’s Disease
    • Posters & Publications
  • News & Media
    • Press Releases
    • Corporate Presentations
    • Events
    • In The News
    • Videos
    • Commentary
    • Podcasts
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • SEC Filings
    • Governance
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Corporate Presentations
  • Events
  • In The News
  • Videos
  • Commentary
  • Podcasts
Jan 18, 2022 7:00am EST

ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to its Scientific Advisory Board

Jan 07, 2022 7:00am EST

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment

Jan 06, 2022 7:30am EST

ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

Dec 16, 2021 7:30am EST

ProMIS Neurosciences Issues Chairman’s Memorandum

Dec 02, 2021 7:00am EST

ProMIS Neurosciences Shareholders Approve Special Resolution

Nov 17, 2021 7:00am EST

A Second Independent Proxy Advisor, ISS, Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation

Nov 12, 2021 7:00am EST

ProMIS Neurosciences Announces Third Quarter 2021 Results

Nov 02, 2021 7:00am EDT

Glass Lewis Recommends ProMIS Neurosciences Shareholders Vote for the Share Consolidation at the Upcoming Special Meeting

Oct 22, 2021 7:00am EDT

ProMIS Neurosciences Announces Update to Senior Management Team

Oct 22, 2021 7:00am EDT

ProMIS Neurosciences Appoints Accomplished Biotech Executive, Dr. Maggie Shafmaster, to its Board of Directors

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …19
  • arrow_forward
Facebook Linkedin Spotify Twitter
©2023 ProMIS Neurosciences, Inc. All Rights Reserved.
Disclaimer Sitemap Cookie Policy Privacy Policy